Moreover, dynamic monitoring of circulating tumor DNA (ctDNA) showed that the mutation rate of AKT1 E17K in peripheral blood increased successively and was correlated with tumor growth, suggesting that the mutation was a possible molecular mechanism underlying HPD in cervical small cell carcinoma. Here, AKT1 is linked to cervical small cell carcinoma.